Aglinin A exhibits significant anti-inflammatory and antioxidant properties, making it a promising candidate for therapeutic applications in chronic inflammatory diseases. It has been studied for its ability to inhibit key pro-inflammatory cytokines and signaling pathways such as NF-κB, which plays a central role in immune response regulation. Due to its natural origin and low cytotoxicity, Aglinin A is being explored for use in dermatological formulations to treat conditions like eczema and psoriasis. Additionally, its antioxidant activity supports potential use in anti-aging skincare products by reducing oxidative stress in skin cells. Research is ongoing into its neuroprotective effects, with preliminary data suggesting it may help mitigate neuronal damage in neurodegenerative disorders.